about
Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensisOral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas diseaseTransforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis.Impairment of protective immunity to blood-stage malaria by concurrent nematode infection.Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.TGF-β-mediated sustained ERK1/2 activity promotes the inhibition of intracellular growth of Mycobacterium avium in epithelioid cells surrogates.Genetic diversity in cytokines associated with immune variation and resistance to multiple pathogens in a natural rodent population.Treg lymphocytes in autoimmune uveitis.Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infectionImmunobiology of visceral leishmaniasis.Is maturation required for Langerhans cell migration?Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effectsGene transfer approaches for the treatment of inflammatory bowel disease.Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter.TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation.Investigation of Transforming Growth Factor-β1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C.Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.Regulatory T cells: friend or foe in immunity to infection?Laser-activated transforming growth factor-β1 induces human β-defensin 2: implications for laser therapies for periodontitis and peri-implantitis.Microbes-induced EMT at the crossroad of inflammation and cancer.Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.Immunomodulation and Disease Tolerance to Staphylococcus aureusRegulatory T cells in virus infections.Transforming growth factor-beta-mediated regulation of BK virus gene expression.Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' diseaseCytokines and their STATs in cutaneous and visceral leishmaniasis.Immunological perspectives of leishmaniasis.Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK.IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection.Expression of Foxp3, TGF-β and IL-10 in American cutaneous leishmaniasis lesions.Blocking pathogen entry into the cell: the future of infectious disease treatment and control?Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in Hamsters
P2860
Q28483511-37E588BC-946D-41E0-B467-DC163B062825Q28484212-04466185-CACB-4425-9E9E-1478A7063E3DQ30394903-54825D94-79F3-4093-973F-2A5CE58D028FQ33788143-C68DD55E-D6A5-4F73-9A07-47B75635FE54Q33883498-BE6F8E8F-FFE1-4974-8AA8-0C16E512DDE8Q33952468-BDACC810-9B50-4EE0-B48B-F365CE29358CQ34062170-DEA74D41-BFE4-4491-95AA-CD27D32171D5Q34273253-4BA39DA8-8EA6-4A83-BA60-9FF60370CBF2Q34492707-9A0DE0F2-85D8-4521-B900-529785B68130Q34641680-76BD3A04-C494-4EE6-8275-E8F0F52FB59CQ34789314-EE43C7D6-F8F7-413B-8E83-87413CD3F881Q34792580-2F949D70-3CF0-4185-82BB-87F01EF79C92Q35122162-71D477EE-E487-4BBE-B1B1-98A4832C16CDQ35544657-7486E173-9EE4-4D70-A03E-ED678E9946B3Q35668744-441DE7C9-6E2A-4CD9-BCE6-D1D4A9A7DE15Q35752922-8AD51B8A-98EC-4DFB-A26C-A7FD421E2FEFQ35764246-E22DE927-5627-4322-94F1-75C127EF4225Q35801788-2BB7E4FB-52B9-45A0-ABE3-9381F50B307DQ35934156-8BC05541-B36D-45D2-9914-7A3ED109B7CCQ36072232-82641AE7-71A9-4797-8F30-D0A6E092F09AQ36187673-629C3DEF-1448-43AA-ACB4-6FC7DDE38E16Q36311439-29411FDA-9D82-4201-A1D6-E5662D9D77CFQ36409380-18CDFBA5-85BD-45F4-B94D-B8DC7EB1A0BEQ36563550-E86000D9-33DB-4F32-8414-61899D1617AFQ36942336-AA93A606-3BF7-4874-953B-7821611523CBQ37409949-2A522A96-4299-49C2-857C-AB5FBD359F88Q37714367-888481D8-98D5-4EE3-806E-95E8DCD3BEDAQ37770420-F0323385-23A0-45B3-9524-C14B728F151FQ40649602-EC54FCF4-2C7E-4788-8ABF-5368BF3D0A62Q41457603-45261A93-9B62-46FE-B1F1-1A1E5D56FD00Q42252111-1871DC32-AD2D-4801-9A60-3B33AFA5E314Q51571019-F45B783E-4DDF-4092-87C3-C4DF8E6D97ADQ52716945-8650F164-AE6D-49CC-9A35-7A1D341D00D1Q58586136-CFBDA1DD-8612-4E23-9ABC-494F4C5BFA18
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
TGF-beta in infections and infectious diseases.
@ast
TGF-beta in infections and infectious diseases.
@en
type
label
TGF-beta in infections and infectious diseases.
@ast
TGF-beta in infections and infectious diseases.
@en
prefLabel
TGF-beta in infections and infectious diseases.
@ast
TGF-beta in infections and infectious diseases.
@en
P1476
TGF-beta in infections and infectious diseases.
@en
P2093
P304
P356
10.1016/S1286-4579(99)00252-X
P577
1999-12-01T00:00:00Z